SEC Form 4 · accession 0001654954-17-010802

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Nov 14, 2017

Accepted (ET)

Nov 16, 2017 · 4:01 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001410098

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	39,969	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Phantom Stock^F2,F1	$0.00	Nov 14, 2017	A	15,625	A	—	—	Common Stock	15,625	0	D
Phantom Stock^F1	—	holding	—	—	—	—	—	Common Stock	20,833	20,833	D
Stock Option (Right to Buy Common Stock)^F3	$2.24	holding	—	—	—	—	Feb 21, 2027	Common Stock	40,000	40,000	D
Restricted Stock Units^F4	—	holding	—	—	—	—	—	Common Stock	15,357	15,357	D
Phantom Stock^F1	—	holding	—	—	—	—	—	Common Stock	3,472	3,472	D
Phantom Stock^F1	—	holding	—	—	—	—	—	Common Stock	4,143	4,143	D
Stock Option (Right to Buy Common Stock)^F5	$3.03	holding	—	—	—	—	Aug 11, 2025	Common Stock	50,000	50,000	D
Phantom Stock^F1	—	holding	—	—	—	—	—	Common Stock	1,415	1,415	D
Stock Option (Right to Buy Common Stock)^F6	$1.91	holding	—	—	—	—	Feb 21, 2026	Common Stock	95,000	95,000	D
Phantom Stock^F1	—	holding	—	—	—	—	—	Common Stock	3,831	3,831	D
Phantom Stock^F1	—	holding	—	—	—	—	—	Common Stock	2,767	2,767	D
Phantom Stock^F1	—	holding	—	—	—	—	—	Common Stock	4,335	4,335	D
Phantom Stock^F1	—	holding	—	—	—	—	—	Common Stock	15,306	15,306	D

F1Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
F2These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation for director's fees.
F3These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
F4These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
F5These options were granted on 8/12/2015. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
F6These options were granted on 2/21/2016. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.